Health Advances is exploring how COVID-19 might change key aspects of the global healthcare industry.

In a series of blog posts, our experts explore a variety of topics, including the prospect for investment in infectious disease prevention, diagnosis and treatment, the role of telemedicine, the challenges of the global healthcare supply chain, the outlook of healthcare reform in the US, the role of non-governmental organizations as brokers between nations, and likely areas of industry consolidation.

We will also consider how these changes may impact other areas of the healthcare industry as resources and regulation serve to change how we provide care.

As COVID-19 revolutionizes healthcare, Health Advances can partner with innovators in infectious disease to bring highly needed solutions to market.

Read Health Advances Blog Series on COVID-19
Introduction
Will Healthcare Ever Be the Same Again After COVID-19?
	APAC AND EUROPEAN MARKETS
US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany? The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19 How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific
	BIOPHARMA
Rapid Responders: How Innovative Technologies are Accelerating Development of New Vaccines The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? COVID-19 Vaccine Development Part 1: Progress and Challenges Part 2: Non-clinical and Early Phase Clinical Development Part 3: Late-stage Clinical Development and Field Trials Biopharma Sales Resilience through Economic Recession The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19 Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks COVID-19 Impact on Rare Disease Patients and Manufacturers SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?eBook: Biopharma in the COVID-19 World Biopharma R&D in the Post-COVID World
	DIAGNOSTICS AND LIFE SCIENCE TOOLS
US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany? The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? How SARS-CoV-2 Will Catalyze Decentralized Testing Value Creation in Molecular Diagnostics: A Game of Luck or Skill? Demystifying SARS-CoV-2 Testing for COVID-19 First Edition Second Edition Third Edition (Part 1) How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen
	HEALTH IT AND DIGITAL HEALTH
How COVID-19 Could Impact Digital Health The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19 eBook: Digital Health and the Global Pandemic
	INVESTORS
The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen
	MARKET ACCESS AND POLICY
How COVID-19 May Redirect US Healthcare Reform Priorities
	MEDTECH
3D Printing in a Pandemic COVID-19 and the Musculoskeletal Industry Part 1: Impact of Past Economic Downturns on the MSK Industry Part 2: The Unique Impact of COVID-19 and Implications for the MSK Industry COVID-19 and the Medtech Industry Procedure Deferral Index ASCs – Accelerating an Already Changing Market The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? How SARS-CoV-2 Will Catalyze Decentralized Testing The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19